France: Apax partners takes majority stake in Porsolt

European PE firm Apax Partners has acquired a majority stake in Porsolt, a global CRO. Apax’s investment, together with that of the management and current shareholders, will allow Porsolt to further grow and implement its strategy to become a comprehensive preclinical service company, addressing the varying therapeutical areas of the global pharma, biotech, and research…

You must be a HMI Subscriber to view this content.

Subscribe Now »